Freshpet director granted 1,589 restricted shares

Kelley Jacki Sue reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/12/2026 - 07:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Kelley Jacki Sue reported acquisition or exercise transactions in this Form 4 filing.

Freshpet, Inc. director Jacki Sue Kelley reported receiving a grant of 1,589 shares of restricted Common Stock as equity compensation. The award was made at no cost and increased her direct holdings to 13,496 shares. These restricted shares vest on March 15, 2027, provided she continues to serve on Freshpet’s Board of Directors through that date.

Insider Trade Summary

Grant/Award: 1,589 shares

Grant/Award 1 txn

Insider Kelley Jacki Sue

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,589	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,496 shares (Direct)

Footnotes (1)

1. F1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Freshpet (FRPT) report for director Jacki Sue Kelley?

Freshpet reported that director Jacki Sue Kelley received a grant of 1,589 shares of restricted Common Stock. The shares were awarded as equity compensation and increased her direct holdings in Freshpet to 13,496 shares following the transaction.

Was the Freshpet (FRPT) share grant to Jacki Sue Kelley an open-market purchase?

No, the transaction was not an open-market purchase. It was a grant of 1,589 restricted Common Stock shares at no cost, awarded under Freshpet’s 2024 Equity Incentive Plan as part of director compensation rather than a discretionary market trade.

When do Jacki Sue Kelley’s restricted Freshpet (FRPT) shares vest?

The 1,589 restricted shares granted to Jacki Sue Kelley vest on March 15, 2027. Vesting is contingent on her continued service on Freshpet’s Board of Directors through that date, aligning the award with long-term board tenure and oversight.

How many Freshpet (FRPT) shares does Jacki Sue Kelley hold after this Form 4 transaction?

After receiving the 1,589-share restricted stock award, Jacki Sue Kelley directly holds 13,496 shares of Freshpet Common Stock. This total reflects her position immediately following the reported grant, as disclosed in the Form 4 insider filing.

Under which plan were the restricted Freshpet (FRPT) shares granted to Jacki Sue Kelley?

The 1,589 restricted Common Stock shares were granted under Freshpet’s 2024 Equity Incentive Plan. This plan is used to provide equity-based compensation, and the award to Jacki Sue Kelley is subject to a vesting schedule tied to continued board service.

What conditions apply to Jacki Sue Kelley’s restricted Freshpet (FRPT) stock award?

The restricted stock award vests only if Jacki Sue Kelley continues serving on Freshpet’s Board of Directors through March 15, 2027. If she does not remain on the board through that date, the unvested portion of the 1,589-share award may not be retained.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelley Jacki Sue

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		1,589(1)	A	$0	13,496	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of restricted Common Stock were awarded to the Reporting Person under the Issuer's 2024 Equity Incentive Plan and vest on March 15, 2027, subject to the Reporting Person's continued service on the Board of Directors of the Issuer at such date.

	/s/ Lisa A. Alexander, as Attorney-in-Fact for the Reporting Person	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.